<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Thursday October 1st 2020 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2020-10-01" ></link>
<id>urn:uuid:9ec87d82-4457-3c73-7672-46f1e67f2384</id>
<updated>2026-06-13T10:44:38-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ARQT: WATANABE TODD FRANKLIN (PR,CEO,DIR) Exercised 3k Options (OE) of ARCUTIS BIOTHERAPEUTICS INC for $1.68 on 9/29, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/arqt/arcutis-biotherapeutics-inc/id-5162359" ></link>
<id>urn:uuid:faac80ec-b7f1-de91-e0b8-882eaf341b9e</id>
<updated>2020-10-01T21:02:10-04:00</updated>
<summary type="html" ><![CDATA[ARCUTIS BIOTHERAPEUTICS INC (ARQT). Recent Price: $24.38. Mkt Cap:3.0B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>ARQT: OSBORNE DAVID W (CTO) Sold (AS) 15k Shares of ARCUTIS BIOTHERAPEUTICS INC for $30.00 on 9/29</title>
<link href="http://www.insiderinsights.com/company/arqt/arcutis-biotherapeutics-inc/id-5162354" ></link>
<id>urn:uuid:f61e7709-1fbd-699c-f80f-a1ce24e0f008</id>
<updated>2020-10-01T21:01:34-04:00</updated>
<summary type="html" ><![CDATA[ARCUTIS BIOTHERAPEUTICS INC (ARQT). Recent Price: $24.38. Mkt Cap:3.0B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>ARQT: SMITHER JOHN W (CFO) Exercised 500 Options (OE) of ARCUTIS BIOTHERAPEUTICS INC for $1.68 on 9/29, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/arqt/arcutis-biotherapeutics-inc/id-5162357" ></link>
<id>urn:uuid:6ad5ab69-5df0-ba2b-3ec2-42e3bc43da72</id>
<updated>2020-10-01T21:00:56-04:00</updated>
<summary type="html" ><![CDATA[ARCUTIS BIOTHERAPEUTICS INC (ARQT). Recent Price: $24.38. Mkt Cap:3.0B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR) Exercised 94,725 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $0.84 on 9/29-10/1, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5162313" ></link>
<id>urn:uuid:300778e0-90e6-8e85-55c9-bad1ac1092fb</id>
<updated>2020-10-01T20:00:14-04:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: ROBINS CHAD M (CEO,CB,DIR) Exercised 2,500 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $0.33 on 9/29-10/1, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5162315" ></link>
<id>urn:uuid:cd9999c2-c2eb-397b-b99b-0a4c8a459a07</id>
<updated>2020-10-01T20:00:13-04:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
</feed>